Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
HB-adMSCs by Hope Biosciences for Parkinson's Disease: Likelihood of Approval
HB-adMSCs is under clinical development by Hope Biosciences and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...
Data Insights
HB-adMSCs by Hope Biosciences for Primary Lateral Sclerosis: Likelihood of Approval
HB-adMSCs is under clinical development by Hope Biosciences and currently in Phase I for Primary Lateral Sclerosis. According to GlobalData,...